⌘K

Home/Filings/4/0001213900-23-099335

4//SEC Filing

Feldmann Marc 4

Accession 0001213900-23-099335

CIK 0001690080other

View on SEC.gov Company Profile

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 6:42 PM ET

Size

4.9 KB

Accession

0001213900-23-099335

Insider Transaction Report

Form 4

Period: 2023-12-28

180 Life Sciences Corp.ATNF

Director10% Owner

Transactions

Award
Common Stock
2023-12-28+135,377→ 250,874 total

Footnotes (1)

[F1]Granted to the Reporting Person pursuant to the Issuer's equity compensation plans in consideration for services rendered. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.

Documents

1 file

4
ownership.xmlPrimary

Issuer

180 Life Sciences Corp.

CIK 0001690080

Entity typeother

Related Parties

1

filerCIK 0001832327

Filing Metadata

Form type: 4
Filed: Dec 27, 7:00 PM ET
Accepted: Dec 28, 6:42 PM ET
Size: 4.9 KB

View on SEC.gov